Insmed To Present at Two March Conferences Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...
Wednesday, March 1, 2023 2 min read
Key Takeaway: Insmed Incorporated, a biopharmaceutical company based in Bridgewater, NJ, announced its upcoming presentations at two investor conferences. The events will be available via live webcast and archived for later access. Insmed is known for its commitment to developing therapies for rare and serious diseases, with a focus on unmet medical needs. Its first commercial product is an approved treatment for a chronic lung disease, indicating its active role in the biopharmaceutical space.
Market Sentiment Analysis
POSITIVE FACTORS
Insmed is committed to transforming lives of patients with serious diseases.
The company has a robust pipeline of investigational therapies.
Insmed's first commercial product is the first-in-disease therapy in multiple regions.
Full Press Release Details
BRIDGEWATER, N.J. , March 1, 2023 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the following investor conferences:
Each fireside chat will be webcast live and can be accessed by visiting the investor relations section of the Company's website at www.insmed.com . Each webcast will be archived for a period of 30 days following the conclusion of the live event.
Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed's first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey , with a footprint across Europe and in Japan . For more information, visit www.insmed.com .